Ondansetron Teva (Ondansetron)

Ondansetron Teva is a selective 5‑HT3 receptor antagonist used to prevent and treat nausea and vomiting in several clinical settings.

• Chemotherapy‑induced nausea and vomiting: helps reduce the frequency and severity of episodes.
• Radiation‑induced nausea and vomiting: provides prophylactic control.
• Post‑operative nausea and vomiting: reduces incidence after surgery.
• Hyper‑emesis gravidarum: used off‑label in some regions to manage severe pregnancy‑related vomiting.
• Anticipatory nausea: helps patients who have learned to feel nausea before treatment.

• Ondansetron blocks the serotonin 5‑HT3 receptors located on vagal afferent nerves in the gastrointestinal tract and in the chemoreceptor trigger zone of the brain. By preventing serotonin from binding to these receptors, it interrupts the signaling pathway that initiates the vomiting reflex, thereby reducing nausea and vomiting.

Side effects of ondansetron are generally mild and dose‑dependent, but they can vary in frequency and severity.

Common Side Effects

• Headache: mild to moderate intensity.
• Constipation: occasional bowel movement changes.
• Diarrhoea: transient loose stools.
• Fatigue: feeling of tiredness.
• Dizziness: light‑headed sensations.

Serious or Rare Side Effects

• QT prolongation: cardiac rhythm changes that may lead to arrhythmia.
• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Serotonin syndrome: rare but potentially life‑threatening when combined with other serotonergic agents.
• Hepatic dysfunction: elevated liver enzymes.
• Vision changes: blurred vision or transient visual disturbances.

When using Ondansetron Teva, certain precautions should be observed to ensure safe and effective therapy.

• Cardiac monitoring: patients with known QT prolongation or electrolyte abnormalities should be monitored.
• Drug interactions: review concomitant medications for serotonergic activity.
• Pregnancy: use only if the potential benefit outweighs the risk.
• Breastfeeding: assess risk versus benefit before use.
• Renal or hepatic impairment: dose adjustment may be required.
• Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Ondansetron may interact with several medications, altering its efficacy or safety profile.

Major Interactions (Avoid)

• Apomorphine: may cause profound hypotension and loss of consciousness.
• Certain anti‑arrhythmic drugs (e.g., quinidine, amiodarone): increase risk of QT prolongation.
• Serotonergic agents (including SSRIs, SNRIs, MAOIs): heightened risk of serotonin syndrome.

Moderate Interaction ( Monitor Closely):

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may increase ondocine ");